CTLA4 and peripheral neuropathy: Conversely, peripheral neuropathy has been associated with CTLA-4 inhibitor therapy (either alone or in conjunction with PDL-1 inhibitors) [7], and cranial neuropathy to CTLA-4 and PDL-1 inhibitors [29].